All In Biotech

Drug Trial Radar · NCT00477451

Staccato Alprazolam in Panic Attack

Investigation of a Single Dose of Staccato™ Alprazolam for Inhalation on Doxapram-Induced Panic Attack in Patients With Panic Disorder

Last checked: Nov 20, 2026Latest source record: Jun 16, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

49

Actual

Start

May 2007

Primary completion

Apr 2008

Study completion Apr 2008

Sponsor

Lead sponsor
Alexza Pharmaceuticals, Inc.Not stated
Sponsor type
Not stated
First posted
May 23, 2007

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 55 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

We are developing Staccato™ Alprazolam for the treatment of Panic attacks associated with panic disorder. This study will provide an initial assessment of efficacy, and to continue to describe the tolerability and pharmacokinetics, of a single inhaled dose of Staccato Alprazolam on a doxapram-induced panic attack in patients with panic disorder.

Conditions

  • Treatment of Induced Panic Attack

Interventions

  • Inhaled placeboDrug

    Inhaled Staccato Alprazolam Placebo

  • Inhaled alprazolam 1 mgDrug

    Inhaled Staccato Alprazolam 1 mg

  • Inhaled alprazolam 2 mgDrug

    Inhaled Staccato Alprazolam 2 mg

  • IV doxapramDrug

    0.5 mg/kg doxapram IV approximately 10s after receiving inhaled alprazolam or placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Doxapram-induced Panic AttackTime frame: 0 to 2 hours
  2. Duration of the Doxapram-induced Panic AttackTime frame: 1 hr post-dose

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • SUNY Downstate Medical Center

    Brooklyn, New York

  • New York State Psychiatric Institute

    New York, New York

  • Mt. Sinai School Of Medicine

    New York, New York

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.